Stealth BioTherapeutics' filing for rare disease drug elamipretide has been turned down by the FDA, although the company says the US regulator has given it a "path forward" for the programme.
Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...
Occasionally, the best stealth games are their own thing, resulting from a developer channeling all the mechanics into the suspense and satisfaction of killing, stealing, and infiltrating unnoticed.